Bacterially expressed and refolded envelope protein (domain III) of dengue virus type-4 binds heparan sulfate. (Q40468636)

20 September 2017

Bacterially expressed and refolded envelope protein (domain III) of dengue virus type-4 binds heparan sulfate. (English)

1 reference

dengue virus envelope protein

20 September 2017

1 reference

1 reference

based on heuristic

inferred from abstract

modulation by virus of host process

0 references

author name string

Priyabrata Pattnaik

1

1 reference

20 September 2017

J Pradeep Babu

2

1 reference

20 September 2017

Shailendra Kumar Verma

3

1 reference

20 September 2017

Vijay Tak

4

1 reference

20 September 2017

P V Lakshmana Rao

5

1 reference

20 September 2017

language of work or name

1 reference

29 September 2006

1 reference

Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences

20 September 2017

1 reference

20 September 2017

846

1 reference

20 September 2017

1-2

1 reference

20 September 2017

184-194

1 reference

Potential effect of population and climate changes on global distribution of dengue fever: an empirical model

20 September 2017

2 references

27 September 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/S0140-6736(02)09964-6

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

Dengue Virus-Specific and Flavivirus Group Determinants Identified with Monoclonal Antibodies by Indirect Immunofluorescence

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

A ligand-binding pocket in the dengue virus envelope glycoprotein

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

Dengue 2 PDK-53 Virus as a Chimeric Carrier for Tetravalent Dengue Vaccine Development

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

4 November 2022

Tissue sulfhydryl groups

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

Identification of a putative coreceptor on Vero cells that participates in dengue 4 virus infection

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

Dengue virus envelope glycoprotein structure: New insight into its interactions during viral entry

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

The global emergence/resurgence of arboviral diseases as public health problems

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

Synergistic neutralizing antibody response to a dengue virus type 2 DNA vaccine by incorporation of lysosome-associated membrane protein sequences and use of plasmid expressing GM-CSF.

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

Recombinant vaccinia viruses co-expressing dengue-1 glycoproteins prM and E induce neutralizing antibodies in mice

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

Biophysical Characterization and Vector-Specific Antagonist Activity of Domain III of the Tick-Borne Flavivirus Envelope Protein

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

Dengue and dengue hemorrhagic fever

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

Neutralization and antibody-dependent enhancement of dengue viruses

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

Expression and purification of Dengue virus type 2 envelope protein as a fusion with hepatitis B surface antigen in Pichia pastoris

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

The production of recombinant dengue virus E protein using Escherichia coli and Pichia pastoris

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

Use of recombinant fusion proteins and monoclonal antibodies to define linear and discontinuous antigenic sites on the dengue virus envelope glycoprotein

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

Dengue: defining protective versus pathologic immunity

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

Formalin-inactivated whole virus and recombinant subunit flavivirus vaccines

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero Cells

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

A functional epitope determinant on domain III of the Japanese encephalitis virus envelope protein interacted with neutralizing-antibody combining sites

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

Resurgent Vector-Borne Diseases as a Global Health Problem

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

Immunization of rhesus monkeys with a recombinant of modified vaccinia virus Ankara expressing a truncated envelope glycoprotein of dengue type 2 virus induced resistance to dengue type 2 virus challenge

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

Altered cytokine responses of dengue-specific CD4+ T cells to heterologous serotypes

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

High-level expression and one-step purification of recombinant dengue virus type 2 envelope domain III protein in Escherichia coli

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

A dengue virus serotype-1 DNA vaccine induces virus neutralizing antibodies and provides protection from viral challenge in Aotus monkeys

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

Dengue virus envelope glycoprotein can be secreted from insect cells as a fusion with the maltose-binding protein

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

Purified dengue 2 virus envelope glycoprotein aggregates produced by baculovirus are immunogenic in mice

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

Development of a purified, inactivated, dengue-2 virus vaccine prototype in Vero cells: immunogenicity and protection in mice and rhesus monkeys

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

Oral immunization of mice with Japanese encephalitis virus envelope protein synthesized in Escherichia coli induces anti-viral antibodies

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

Measurement of protein using bicinchoninic acid

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

Dengue: emergence as a global public health problem and prospects for control

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

Characterization of dengue-2 virus binding to surfaces of mammalian and insect cells.

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein.

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

Mapping of a dengue virus neutralizing epitope critical for the infectivity of all serotypes: insight into the neutralization mechanism

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

Demonstration of binding of dengue virus envelope protein to target cells

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

A recombinant envelope protein from Dengue virus purified by IMAC is bioequivalent with its immune-affinity chromatography purified counterpart

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

Progress in development of a live-attenuated, tetravalent dengue virus vaccine by the United States Army Medical Research and Materiel Command.

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

rDEN4delta30, a live attenuated dengue virus type 4 vaccine candidate, is safe, immunogenic, and highly infectious in healthy adult volunteers

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

Evaluation by flow cytometry of antibody-dependent enhancement (ADE) of dengue infection by sera from Thai children immunized with a live-attenuated tetravalent dengue vaccine

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

Affinity-purified dengue-2 virus envelope glycoprotein induces neutralizing antibodies and protective immunity in mice

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

Mice immunized with a dengue type 2 virus E and NS1 fusion protein made in Escherichia coli are protected against lethal dengue virus infection

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

Analysis of the steps involved in Dengue virus entry into host cells

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

Evaluation of the protective efficacy of a recombinant dengue envelope B domain fusion protein against dengue 2 virus infection in mice.

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

VACCINATION OF HUMAN VOLUNTEERS WITH MONOVALENT AND TETRAVALENT LIVE-ATTENUATED DENGUE VACCINE CANDIDATES

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

Genetically modified, live attenuated dengue virus type 3 vaccine candidates

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

Induction of neutralizing antibodies specific to dengue virus serotypes 2 and 4 by a bivalent antigen composed of linked envelope domains III of these two serotypes

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2006.08.051

10.1016/J.JCHROMB.2006.08.051

4 November 2022

Identifiers

DOI

1 reference

20 September 2017

1 reference